NCT03966911 - Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics | Biotech Hunter

Enrollment

335

Participants

Timeline

Start Date

June 14, 2019

Primary Completion Date

May 13, 2020

Study Completion Date

May 13, 2020

Conditions

Type 1 Diabetes MellitusType2 Diabetes Mellitus

Interventions

DEVICE

Guardian™ Sensor (3) connected to a Guardian™ Connect Transmitter

Continuous Glucose Monitoring and frequent sample testing

Trial Locations (15)

22903

University of Virgina, Charlottesville

33613

University of South Florida, Tampa

38133

AM Diabetes & Endocrinology Center, Bartlett

50265

IDERC, Des Moines

55905

Mayo Clinic (Rochester MN), Rochester

78749

Texas Diabetes and Endocrinology, Austin

80045

Barbara Davis Center - Adults, Aurora

Barbara Davis Center for Childhood Diabetes (Pediatric), Aurora

83404

Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls

90505

SoCal Diabetes, Torrance

92025

Diablo Clinical Research, Walnut Creek

92026

AMCR Institue, Escondido

93105

Sansum Diabetes Research Institute, Santa Barbara

94598

Diablo Clinical Research, Walnut Creek

98057

Rainer Clinical Research Center, Renton

All Listed Sponsors

lead

Medtronic Diabetes

INDUSTRY